Literature DB >> 27145197

Ex-vivo normothermic perfusion in renal transplantation: past, present and future.

Cissy Yong1, Sarah A Hosgood, Michael L Nicholson.   

Abstract

PURPOSE OF REVIEW: Marginal donor kidneys make up a substantial proportion of transplanted kidneys. Nonetheless, they are more susceptible to injury during procurement and preservation. Normothermic perfusion is an alternative method of organ preservation that can be used to improve the quality, resuscitate, assess and potentially repair the organ. This review provides an up-to-date summary of the role of normothermic perfusion in renal transplantation and what we can expect in the future. RECENT
FINDINGS: Normothermic perfusion has been demonstrated to be a feasible and well tolerated method of organ preservation in a series of extended criteria donor kidneys. Furthermore, normothermic perfusion can be used as a quality assessment tool for kidneys pretransplant. In the future, normothermic perfusion could be used to manipulate the organ using gene and stem cell therapies ameliorating renal function after injury.
SUMMARY: In the last 5 years, normothermic perfusion has been translated from an experimental laboratory technique into clinical practice with promising results. Normothermic perfusion has demonstrated itself to be multifaceted in its application in renal transplantation. It may improve early graft function and can be used to assess the quality of the kidney before transplantation. The implications of these applications are crucial in maximizing the use of donor organs available in the perpetual climate of organ shortage.

Entities:  

Mesh:

Year:  2016        PMID: 27145197     DOI: 10.1097/MOT.0000000000000316

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  6 in total

1.  Synthetic hemoglobin-based oxygen carriers are an acceptable alternative for packed red blood cells in normothermic kidney perfusion.

Authors:  Mohamed M Aburawi; Fermin M Fontan; Negin Karimian; Corey Eymard; Stephanie Cronin; Casie Pendexter; Sonal Nagpal; Peony Banik; Sinan Ozer; Paria Mahboub; Francis L Delmonico; Heidi Yeh; Korkut Uygun; James F Markmann
Journal:  Am J Transplant       Date:  2019-04-26       Impact factor: 8.086

2.  Prolongation of allograft survival by passenger donor regulatory T cells.

Authors:  Ines G Harper; Olivera Gjorgjimajkoska; Jacqueline H Y Siu; Jasvir Parmar; Arend Mulder; Frans H J Claas; Sarah A Hosgood; Michael L Nicholson; Reza Motallebzadeh; Gavin J Pettigrew
Journal:  Am J Transplant       Date:  2019-02-05       Impact factor: 8.086

3.  Cold Preflush of Porcine Kidney Grafts Prior to Normothermic Machine Perfusion Aggravates Ischemia Reperfusion Injury.

Authors:  Gregor Fabry; Benedict M Doorschodt; Tim Grzanna; Peter Boor; Aaron Elliott; André Stollenwerk; René H Tolba; Rolf Rossaint; Christian Bleilevens
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

Review 4.  Risk Factors of Rejection in Renal Transplant Recipients: A Narrative Review.

Authors:  Hani Oweira; Ali Ramouz; Omid Ghamarnejad; Elias Khajeh; Sadeq Ali-Hasan-Al-Saegh; Rajan Nikbakhsh; Christoph Reißfelder; Nuh Rahbari; Arianeb Mehrabi; Mahmoud Sadeghi
Journal:  J Clin Med       Date:  2022-03-03       Impact factor: 4.241

Review 5.  Advances in Perfusion Systems for Solid Organ Preservation.

Authors:  Sara Salehi; Kenny Tran; Warren L Grayson
Journal:  Yale J Biol Med       Date:  2018-09-21

6.  Genetic Engineering of the Kidney to Permanently Silence MHC Transcripts During ex vivo Organ Perfusion.

Authors:  Yuliia Yuzefovych; Emilio Valdivia; Song Rong; Franziska Hack; Tamina Rother; Jessica Schmitz; Jan Hinrich Bräsen; Dirk Wedekind; Cyril Moers; Nadine Wenzel; Faikah Gueler; Rainer Blasczyk; Constanca Figueiredo
Journal:  Front Immunol       Date:  2020-02-19       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.